PINK1 and ovarian cancer: A recent pan-cancer analysis indicated that PINK1 mRNA expression was lower in several cancer groups than in normal tissues, including the brain, breast, colorectal, oesophageal, head and neck, liver and ovarian cancers, as well as leukemia and melanoma, and higher in diffuse large B-cell lymphoma [21].